Innovent and SanegeneBio partner for hypertension drug development
Innovent Biologics has signed a partnership agreement with Sanegene Bio to jointly develop a siRNA drug candidate, SGB-3908, to treat hypertension.
Weimin Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Weimin Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Weimin Wang Today - Breaking & Trending Today
Partnership to identify target Peptides
Start-up SanegeneBio Inc, focused on developing novel RNAi-based medicines has entered into a Master Service Agreement with Orbit Discovery (Oxford UK), a leader in the discovery of therapeutic peptide hits. Click to read more...
Source: labmate-online.com
Orbit Discovery and SanegeneBio Collaborate to Identify Targeting Peptides for RNAi Drugs
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc., (Sanegene), a start-up company
Source: finanznachrichten.de
SanegeneBio and Orbit join forces to establish targeting peptides
Agreement covers cell-based studies, with an additional option to further develop screening activities - News - PharmaTimes
Source: pharmatimes.com
Western Resources Reports AGM Results
Western Resources Reports AGM Results Western Resources Corp. is pleased to announce that its shareholders approved all items put before them at the Company’s Annual General Meeting held in its Vancouver office and virtually on March 12, 2021. At the meeting, Western’s shareholders: Set the number of directors of the Company at six ; Elected Wenye Xue, Weimin Wang, Guy Bentinck, George Gao, Andrew Hancharyk, Yujia Ren to the Board of Directors; … Western Resources Corp. (TSX: WRX) (“Western” or “the Company”) is pleased to announce that its shareholders approved all items put be...
Source: investingnews.com